Susanne Moira Brown

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Crusade Laboratories Limited, Virttu Biologics Limited, The Wistar Institute. Active years: 2000-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanne Moira Brown. Retrieved from https://idiyas.com/inventor/susanne-moira-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 61.5

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 63(Granted Patents)

Company Filing History:

5 out of 5

Crusade Laboratories Limited

patents

4 out of 9

Virttu Biologics Limited

University of Glasgow

patents

5. 1 out of 259

Medical Research Council

patents

6. 1 out of 519

Sloan-Kettering Institute for Cancer Research

patents

7. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8969063 - Herpes simplex viruses and methods of viral replication (2015-03-03),

2. 8778684 - Herpes simplex virus complex (2014-07-15),

3. 8530437 - Methods for treating cancer using herpes simplex virus expressing antisense to the squamous cell carcinoma related oncogene (2013-09-10),

4. 8163292 - Herpes simplex viruses and methods of viral replication (2012-04-24),

5. 8067012 - Treatment of melanoma using HSV mutant (2011-11-29),

6. 7943144 - Herpes simplex virus complex (2011-05-17),

7. 7897146 - Treatment using herpes simplex virus (2011-03-01),

8. 7674468 - Treatment of cancer using HSV mutant (2010-03-09),

9. 7498161 - Mutant herpes simplex viruses comprising nucleic acid encoding a nitroreductase (2009-03-03),

10. 6641995 - Methods for identifying cell cycle regulators (2003-11-04),

11. 6423528 - Herpes simplex virus-1 deletion variants and vaccines thereof (2002-07-23),

12. 6235467 - Methods for identifying cell cycle regulators (2001-05-22),

13. 6040169 - Herpes simplex virus-1 deletion variants and vaccines thereof (2000-03-21),

Title: The Innovative Contributions of Susanne Moira Brown

Introduction

Susanne Moira Brown is a prominent inventor based in Glasgow, GB. He has made significant contributions to the field of virology, particularly in the development of herpes simplex virus technologies. With a total of 13 patents to his name, Brown's work has the potential to impact medical treatments and therapies.

Latest Patents

Among his latest patents, Brown has developed innovative methods related to herpes simplex viruses and their replication. One notable patent discloses a herpes simplex virus genome that includes a nucleic acid sequence encoding an ING4 polypeptide. Another significant patent presents an HSV complex that comprises an avirulent HSV and a targeting agent. This complex allows the HSV particle to specifically infect and lyse targeted cells, such as cancer cells, by incorporating an antibody binding domain into one or more viral glycoproteins.

Career Highlights

Throughout his career, Susanne Moira Brown has worked with various companies, including Crusade Laboratories Limited and Virttu Biologics Limited. His expertise in virology and innovative approaches to viral therapies have positioned him as a key figure in the industry.

Collaborations

Brown has collaborated with notable individuals in his field, including Joe Conner and Alasdair Roderick MacLean. These partnerships have further enhanced his research and development efforts.

Conclusion

Susanne Moira Brown's contributions to the field of virology through his patents and collaborations highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic approaches in treating viral infections.

Profile summary based on public USPTO records.